Drug intelligence / Profile preview

fenclofenac

Development stage
Discontinued
Modality
Small Molecules
Administration
Ophthalmic, Oral, Topical
01

Overview

Fenclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that was previously used to treat rheumatism and other inflammatory conditions. It possesses anti-inflammatory, analgesic, and antipyretic properties. Fenclofenac acts primarily by inhibiting the cyclooxygenase enzymes COX-1 and COX-2, leading to reduced synthesis of prostaglandins involved in pain, inflammation, and fever[2][3][4]. The drug also exhibits mild immunosuppressive effects and can displace thyroid hormones from their binding proteins, which may affect thyroid function[1][5][8]. Despite passing animal toxicity tests in multiple species, fenclofenac was found to cause severe liver toxicity in humans. Due to its side effects—including hepatotoxicity and potential for causing lichen planus—it was withdrawn from the market in the UK (1984) and US during the 1980s[1][2][7]. Indications included pain management (such as dysmenorrhea), ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, actinic keratosis, and general rheumatic diseases[2].

Brand names
Flenac
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on fenclofenac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fenclofenac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call